These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 21872450
1. Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. Bassetti M, Mesini A, Molinari MP, Viscoli C. Int J Antimicrob Agents; 2011 Nov; 38(5):453-4. PubMed ID: 21872450 [No Abstract] [Full Text] [Related]
4. Vancomycin minimum inhibitory concentrations (MICs) for meticillin-resistant Staphylococcus aureus (MRSA) in Hong Kong. Ip M, Chau SS, Lui SL, Leung E, Ling T. Int J Antimicrob Agents; 2010 Oct; 36(4):386-7. PubMed ID: 20702065 [No Abstract] [Full Text] [Related]
5. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S. J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024 [Abstract] [Full Text] [Related]
6. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR. J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366 [Abstract] [Full Text] [Related]
9. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients. Wang JL, Lai CH, Lin HH, Chen WF, Shih YC, Hung CH. Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465 [Abstract] [Full Text] [Related]
10. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia. Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR. Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565 [Abstract] [Full Text] [Related]
13. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader HS, Jones RN, Rossi KL, Rybak MJ. J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978 [Abstract] [Full Text] [Related]
18. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant]. Lepe JA, Gil-Navarro MV, Santos-Rubio MD, Bautista J, Aznar J. Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023 [Abstract] [Full Text] [Related]
19. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. Ho PL, Lo PY, Chow KH, Lau EH, Lai EL, Cheng VC, Kao RY. J Infect; 2010 Feb; 60(2):140-5. PubMed ID: 19961873 [Abstract] [Full Text] [Related]
20. In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC. Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS. Diagn Microbiol Infect Dis; 2012 Jul; 73(3):264-6. PubMed ID: 22621914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]